Circulating plasma miR222-3P status and its potential diagnostic performance in prostate cancer.

Zohreh Heydari,Emadoddin Moudi,Farzin Sadeghi,Mahmoud Hajiahmadi,Setareh Rezatabar,Nahid Neamati,Hadi Parsian

The journal of gene medicine（2022）

引用 2|浏览3

暂无评分

摘要

Circulating plasma miR-222-3p significantly upregulated in PC patients, but not in BPH ones. Besides these preliminary results showed that miR222-3p has the potential to discriminate PC patients from healthy ones. Addittional studies with a larger sample size are required to confirm these data.

查看译文

关键词

diagnostic performance,miR222-3p,plasma,prostate cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要